HAL 抗体 (N-Term)
Quick Overview for HAL 抗体 (N-Term) (ABIN630816)
抗原
See all HAL 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- N-Term
-
特异性
- HAL antibody was raised against the N terminal of HAL
-
纯化方法
- Affinity purified
-
免疫原
- HAL antibody was raised using the N terminal of HAL corresponding to a region with amino acids INKLQELQVNLVRSHSSGVGKPLSPERCRMLLALRINVLAKGYSGISLET
-
-
-
-
应用备注
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
说明
-
HAL Blocking Peptide, (ABIN939461), is also available for use as a blocking control in assays to test for specificity of this HAL antibody
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
溶解方式
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of HAL antibody in PBS
-
浓度
- Lot specific
-
缓冲液
- PBS
-
注意事项
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
储存条件
- 4 °C/-20 °C
-
储存方法
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- HAL (Histidine Ammonia-Lyase (HAL))
-
别名
- HAL
-
背景
- HAL is a cytosolic enzyme catalyzing the first reaction in histidine catabolism, the nonoxidative deamination of L-histidine to trans-urocanic acid. HAL defects cause histidinemia which is characterized by increased histidine and histamine and decreased urocanic acid in body fluids.
-
分子量
- 72 kDa (MW of target protein)
抗原
-